KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia paxalisib preclinical DIPG data released at IPSNO, page-13

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,515 Posts.
    lightbulb Created with Sketch. 337
    Play the ball - somethings can legitimately be laid at management's feet 100% - I think we left the shrine environment way back didn't we? having said that simply going off with a shotgun hoping at least one pallet will hit is also not worth the response and does nothing to lift the quality of discourse here.

    External factors are hitting everyone who are not producing cash which means Kazia management are going to need to be that much more strategic in their thinking going forward. The days of easy money are over - that being said I never wanted to park cash in a hot air machine either playing the pump and dumps so the situation as always returns to the drugs - they work (in humans) or they don't. - paxalisib is attracting attention in a poorly endowed area of oncology in regard available treatments and yesterdays announcement was positive IMHO in regard the ongoing development of paxalisib.

    Last edited by Pbnewby: 15/06/22
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.